论文部分内容阅读
目的:观察坤宁口服液对于促进剖宫产术后子宫复旧的临床疗效。方法:选择60例剖宫产术后患者,随机分成治疗组和对照组,两组术后均予西医常规治疗,治疗组在此基础上于术后第2天加用坤宁口服液治疗,疗程为7d。比较两组子宫底高度,超声检查子宫复旧情况及血性恶露持续时间。结果:两组术后第2、3、4天子宫底下降高度组间比较,差异均无统计学意义(P>0.05);两组术后第7天B超测量子宫大小比较,差异无统计学意义(P>0.05),第42天治疗组子宫三径之和小于对照组,差异有统计学意义(P<0.01);血性恶露持续时间治疗组短于对照组,差异有统计学意义(P<0.05)。结论:坤宁口服液促进剖宫产术后子宫复旧疗效显著。
Objective: To observe the clinical efficacy of Kunning oral solution in promoting uterine involution after cesarean section. Methods: Sixty patients with cesarean section were selected and randomly divided into treatment group and control group. Both groups were treated routinely with western medicine. The treatment group was treated with Kunning oral solution on the second day after operation. Treatment for 7d. The two groups were compared at the end of the uterus, ultrasound examination of uterine involution and bloody lochia duration. Results: There was no significant difference between the two groups in the descending height of the uterus at the 2nd, 3rd, 4th day after operation (P> 0.05). There was no statistical difference in the uterine size between the two groups (P> 0.05). The sum of the three diameters of the uterus in the treatment group on the 42nd day was smaller than that of the control group (P <0.01), and the duration of bloody lochia was shorter in the treatment group than in the control group (P <0.05) P <0.05). Conclusion: Kunning oral liquid to promote uterine involution after cesarean section significant effect.